Pegavision Corporation (6491.TW)

TWD 361.5

(-0.14%)

Operating Expenses Summary of Pegavision Corporation

  • Pegavision Corporation's latest annual operating expenses in 2023 was 1.68 Billion TWD , up 5.83% from previous year.
  • Pegavision Corporation's latest quarterly operating expenses in 2024 Q3 was 400.06 Million TWD , up 3.9% from previous quarter.
  • Pegavision Corporation reported a annual operating expenses of 1.5 Billion TWD in annual operating expenses 2022, up 0.48% from previous year.
  • Pegavision Corporation reported a annual operating expenses of 1.49 Billion TWD in annual operating expenses 2021, up 30.56% from previous year.
  • Pegavision Corporation reported a quarterly operating expenses of 385.03 Million TWD for 2024 Q2, up 1.52% from previous quarter.
  • Pegavision Corporation reported a quarterly operating expenses of 400.06 Million TWD for 2024 Q3, up 3.9% from previous quarter.

Annual Operating Expenses Chart of Pegavision Corporation (2023 - 2012)

Historical Annual Operating Expenses of Pegavision Corporation (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 1.68 Billion TWD 5.83%
2022 1.5 Billion TWD 0.48%
2021 1.49 Billion TWD 30.56%
2020 1.14 Billion TWD 26.89%
2019 902.61 Million TWD 11.23%
2018 811.49 Million TWD 17.13%
2017 692.82 Million TWD 14.84%
2016 603.3 Million TWD 13.26%
2015 532.69 Million TWD 39.06%
2014 383.07 Million TWD 35.42%
2013 282.88 Million TWD 98.86%
2012 142.25 Million TWD 0.0%

Peer Operating Expenses Comparison of Pegavision Corporation

Name Operating Expenses Operating Expenses Difference
Nang Kuang Pharmaceutical Co., Ltd. 495.65 Million TWD -240.395%
Maxigen Biotech Inc. 274.24 Million TWD -515.209%
SciVision Biotech Inc. 312.85 Million TWD -439.281%
Bionime Corporation 673.63 Million TWD -150.458%
Visco Vision Inc. 522.44 Million TWD -222.935%